Generate a tailored SOP for Dr. Roger Greenberg. Improve your application with a focused, well-structured draft.
Roger Greenberg is a professor in the Department of Cancer Biology at the Perelman School of Medicine at the University of Pennsylvania. His research focuses on understanding the basic mechanisms of DNA repair and its impact on genome integrity and cancer etiology, particularly in the context of targeted therapies. He investigates the BRCA1 and BRCA2 genes, which are critical for the homologous recombination repair mechanisms that maintain genome stability. His work has revealed insights into how BRCA1 interacts with DNA damage sites and the role of various proteins involved in these processes. Additionally, Greenberg's laboratory researches the role of telomeres in cancer cell immortality and how alternative lengthening of telomeres may provide challenges for treatment. His contributions have advanced the understanding of cancer biology, especially regarding the interplay between DNA damage responses and the immune system. He is actively exploring innovative approaches to enhance the efficacy of cancer therapies by combining DNA damaging treatments with immune checkpoint blockade.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.